ArticleThe Journal of clinical investigation2000

A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.

L Visentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.